obesity drug news today october 2025 glp-1 A network meta-analysis backed weight-loss benefits with several receptor agonists, with less certainty for newer-generation agents. Read more at the link in bio The first issue of New
Description
Adapting to these market shifts, Nestl is launching Vital Pursuit, a new line of frozen food products specifically for consumers on weight loss medications like Ozempic and Wegovy
A systematic review
Looking for support with Weight loss
Gallstone disease was also linked with the long-term use of GLP-1 agonist drugs
S.MollerM.et al (1996)
After her weight rose from about 50kg at university to 72kg in 2024, the medication helped her lose about 8kg in the first six months, bringing her weight down to about 60kg
